文献速递免疫规划慢病防控与筛查

实体器官移植受者中新型冠状病毒mRNA疫苗接种后排斥反应发生时间分析

Timing of rejection events preceded by Covid-19 mRNA vaccination in recipients of solid organ transplants.
PubMed 文献 · Vaccine · 2024-12-18

研究纳入2020至2022年诊断为急性排斥且既往接种过SARS-CoV-2疫苗的实体器官移植受者45例,分析末次接种至排斥的间隔时间。中位间隔为102天(IQR 48-178),时间分布连续无可识别模式,不支持疫苗接种在排斥中起作用。结论认为SARS-CoV-2 mRNA疫苗不太可能触发实体器官移植受者排斥。

要点

  • 45例实体器官移植受者中,末次SARS-CoV-2疫苗接种至急性排斥的中位间隔为102天(IQR 48-178)。
  • 接种至排斥的间隔时间呈连续分布,无可识别的时间模式。
  • 结论认为SARS-CoV-2 mRNA疫苗不太可能触发实体器官移植受者排斥。

核心结论

  • SARS-CoV-2 mRNA疫苗接种不太可能触发实体器官移植受者的排斥反应。

研究设计与样本

  • 研究识别2020至2022年诊断为急性排斥且既往接种过SARS-CoV-2疫苗的所有实体器官移植受者,分析疫苗接种与排斥之间的延迟是否恒定。

主要发现

  • 共识别45例患者,末次SARS-CoV-2疫苗接种至排斥的中位延迟为102天(IQR 48-178)。
  • 该延迟呈连续分布,无可识别的时间模式,不支持疫苗接种在排斥中起作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: SARS-CoV-2 mRNA vaccine reactogenicity has raised concerns regarding the risk of rejection in solid organ transplant recipients. We explored whether SOT recipients diagnosed with acute rejection had previously received a vaccine injection within a timeframe consistent with a causal link. METHODS: We identified all SOT recipients with a diagnosis of acute rejection from 2020 to 2022 and who had previously received a SARS-CoV-2 vaccination, and analysed whether the delay between vaccination and rejection was constant. RESULTS: In the 45 identified patients, median delay between the last SARS-CoV-2 vaccination and the rejection was 102 days [IQR 48-178]; the continuous distribution of this delay, with no identifiable time pattern, is not in favor of a role of vaccination in rejection. CONCLUSION: SARS-CoV-2 mRNA vaccination is unlikely to trigger rejection in SOT recipients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Perrier Q, Noble J, Bonadona A, et al. Timing of rejection events preceded by Covid-19 mRNA vaccination in recipients of solid organ transplants. Vaccine. 2024. PMID: 39700906. doi:10.1016/j.vaccine.2024.126617

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。